Clearmind Medicine (NASDAQ: CMND) registers 22.6M resale shares tied to $10M notes

Clearmind Medicine Inc. (NASDAQ: CMND) has filed a Form F-3 to register for resale up to 22,626,988 common shares. These shares are tied to the conversion of up to $10.0M in principal plus accrued interest from convertible promissory notes held by institutional investors, assuming a conversion price of $0.60 per share, which represents approximately 222% of pre-offering outstanding shares. The company will not receive any proceeds from the resale of these registered shares, as all net proceeds will go to the selling shareholders, but it has already received $8.15M in gross proceeds from the promissory notes.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin